User profiles for EVANGELIA LEGAKI

Legaki Evangelia

National and kapodistrian Univeristy of Athens
Verified email at med.uoa.gr
Cited by 839

[HTML][HTML] Risk factors for gastroesophageal reflux disease and analysis of genetic contributors

A Argyrou, E Legaki, C Koutserimpas… - World journal of …, 2018 - ncbi.nlm.nih.gov
Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder with an
increasing prevalence. GERD develops when the reflux of stomach contents causes …

[HTML][HTML] Influence of environmental factors in the development of inflammatory bowel diseases

E Legaki, M Gazouli - World journal of gastrointestinal …, 2016 - ncbi.nlm.nih.gov
Idiopathic inflammatory bowel diseases (IBD), Crohn’s disease (CD) and ulcerative colitis (UC),
are multifactorial diseases that are manifested after disruption of a genetic predisposed …

[HTML][HTML] Inflammatory bowel disease pathobiology: the role of the interferon signature

NP Andreou, E Legaki, M Gazouli - Annals of gastroenterology, 2020 - ncbi.nlm.nih.gov
The pathogenesis of inflammatory bowel disease (IBD) is still unclear, but includes both
inflammatory and autoimmune reactions. Current methodological approaches could better …

DNA methylation biomarkers in asthma and rhinitis: are we there yet?

E Legaki, C Arsenis, S Taka… - Clinical and …, 2022 - Wiley Online Library
The study of epigenetics has improved our understanding of mechanisms underpinning
gene‐environment interactions and is providing new insights in the pathophysiology of …

Serum proteomic signatures of male breast cancer

…, A Papadopoulou, E Legaki… - Cancer Genomics & …, 2019 - cgp.iiarjournals.org
Background: To date, the elucidation of serum protein alterations in male breast cancer (MBC)
has not been extensively studied, due to the rarity of the disease. Materials and Methods: …

B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab …

NP Andreou, E Legaki, N Dovrolis, N Boyanov… - Digestive and Liver …, 2021 - Elsevier
Background Several studies correlated elevated B-cell activating factor (BAFF) levels and
its polymorphisms (SNPs) in patients with autoimmunity. Limited data existed regarding the …

Type I and II interferon signatures can predict the response to anti-TNF agents in inflammatory bowel disease patients: Involvement of the microbiota

…, N Dovrolis, NP Andreou, E Legaki… - Inflammatory Bowel …, 2020 - academic.oup.com
Background Anti-TNF agents have been a cornerstone of IBD therapy; however, response to
treatment has been variable, and clinically applicable biomarkers are urgently needed. We …

[HTML][HTML] Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease

…, M Gazouli, CI Dovas, E Legaki… - BMC veterinary …, 2020 - Springer
Background Canine inflammatory bowel disease (IBD) is a group of chronic gastrointestinal
(GI) disorders of still largely unknown etiology. Canine IBD diagnosis is time-consuming and …

[HTML][HTML] Development of a point-of-care system based on white light reflectance spectroscopy: Application in CRP determination

D Tsounidi, G Koukouvinos, V Christianidis, E Legaki… - Biosensors, 2021 - mdpi.com
The development of methods and miniaturized systems for fast and reliable quantitative
determinations at the Point-of-Care is a top challenge and priority in diagnostics. In this work, a …

Association of alcohol use disorder risk with ADH1B, DRD2, FAAH, SLC39A8, GCKR, and PDYN genetic polymorphisms

E Legaki, D Tsaklakidou, A Hatzimanolis, E Segredou… - in vivo, 2022 - iv.iiarjournals.org
Background/Aim: Alcohol use disorder (AUD) is a chronic, multifactorial psychiatric condition
with an enormous impact on public health and social cost. Genetic studies suggest a …